PDF(1417 KB)
PDF(1417 KB)
PDF(1417 KB)
小鼠胚胎干细胞定向诱导为胰岛样细胞过程中印记基因变化
Expression of imprinted genes during the course of differentiation from mouse embryonic stem cells to islet-like cells in vitro
目的：探讨体外诱导对小鼠胚胎干细胞株SF1-G印记基因Kcnq1、Cdkn1c的影响。方法：体外诱导小鼠胚胎干细胞SF1-G向胰岛样细胞分化，RT-PCR和细胞免疫荧光检测胰岛细胞标志基因表达；聚合酶链式反应-限制性内切酶片段长度多态性 (PCR-RFLP)检测印记基因Kcnq1、Cdkn1c在分化各阶段细胞中的亲本表达情况。结果：胰岛细胞标志性基因Insulin、Glucagon、Somatostatin、IAPP、Glut2在诱导分化后的细胞都有表达；分化终末细胞能表达胰岛细胞特异性蛋白胰岛素、C肽及Somastatin；PCR-RFLP检测分析显示，体外诱导分化后细胞的印记基因Kcnq1、Cdkn1c呈双等位基因表达。结论：胚胎干细胞经体外诱导培养可定向分化为胰岛样细胞；用此种分化方法可导致胚胎干细胞印记基因表达的改变，出现印记丢失。［中国当代儿科杂志，2010，12(12)：954-958］
OBJECTIVE: To study the effects of in vitro inducement on the expression of SF1-G imprinted genes, Kcnq1 and Cdkn1c during the course of differentiation from mouse embryonic stem (ES) cells to islet-like cells. METHODS: Mouse ES cells were induced to differentiate into islet-like cells in vitro. The expression of islet specific markers was tested by RT-PCR or immunofluorescence. RT-PCR/RFLP was used to test the imprinted genes parental expression in cells at different stages. RESULTS: Islet specific genes, such as Insulin, Glucagon, Somatostatin, IAPP and Glut2, were expressed in differentiated cells. The proteins of insulin, C-peptide and Somastatin were expressed in the final stage cells. Imprinted gene Kcnq1 and Cdkn1c were biallelicly expressed in islet-like cells. CONCLUSIONS: Mouse ES cells can be successfully induced into islet-like cells in vitro. Gene imprinting status of Kcnq1 and Cdkn1c may be changed in differentiated cells (causing loss of imprinting) during the in vitro inducement.［Chin J Contemp Pediatr, 2010, 12 (12):954-958］
胚胎干细胞 / 分化 / 印记丢失 / 胰岛样细胞 / 小鼠
Embryonic stem cell / Differentiation / Loss of imprinting / Islet-like cell / Mice
［1］Brignier AC, Gewirtz AM. Embryonic and adult stem cell therapy［J］. J Allergy Clin Immunol, 2010, 125(2 Suppl 2): S336-S344.
［2］Morison IM, Reeve AE. A catalogue of imprinted genes and Parent-of-origin effects in humans and animals［J］. Hum Mol Genet, 1998, 7(10): 1599-1609.
［3］Ubeda F, Wilkins JF. Imprinted genes and human disease: an evolutionary perspective［J］. Adv Exp Med Biol, 2008, 626:101-115.
［4］Humpherys D, Eggan K, Akutsu H, Hochedlinger K, Rideout WM 3rd, Biniszkiewicz D, et al. Epigenetic instability in ES cells and cloned mice［J］. Science, 2001，293(5527): 95-97.
［5］Li T, Vu TH, Ulaner GA, Littman E, Ling JQ, Chen HL, et al. IVF results in de novo DNA methylation and histone metylation at an Igf2-H19 imprinting epigenetic switch［J］. Mol Hum Reprod, 2005,11(9): 631-640.
［6］Shi Y, Hou L, Tang F, Jiang W, Wang P, Ding M, et al. Inducing embryonic stem cells to differentiate into pancreatic beta cells by a novel threestep approach with activin A and all-trans retinoic acid［J］. Stem Cells, 2005, 23(5): 656-662.
［7］Chellappan SP, Giordano A, Fisher PB. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development［J］. Curr Top Microbiol Immunol, 1998, 227: 57-103.
［8］Reid LH, Crider-Miller SJ, West A, Lee MH, Massagué J, Weissman BE. Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms tumor assay［J］. Cancer Res, 1996, 56(6):1214 -1218.
［9］Vlachos P, Nyman U, Hajji N, Joseph B. The cell cycle inhibitor p57(Kip2) promotes cell death via the mitochondrial apoptotic pathway［J］. Cell Death Differ, 2007, 14(8): 1497-1507.
［10］Kassem SA, Ariel I, Thornton PS, Hussain K, Smith V, Lindley KJ, et al. p57(KIP2) expression in normal islet cells and in hyperinsulinism of infancy［J］. Diabetes, 2001, 50(12): 2763-2769.
［11］Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias［J］. Nat Genet, 1996, 12 (1): 17-23.
［12］Jespersen T, Grunnet M, Olesen SP. The KCNQ1 potassium channel: from gene to physiological function［J］. Physiology (Bethesda), 2005, 20: 408-416.
［13］Lee MP, Hu RJ, Johnson LA, Feinberg AP. Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beck with-Wiedemann syndrome chromosomal rearrangements［J］. Nat Genet, 1997, 15(2): 181-185.
［14］Paulsen M, El-Maarri O, Engemann S, Str-dicke M, Franck O, Davies K, et al. Sequence conservation and variability of imprinting in the Beckwith-Wiedemann syndrome gene cluster in human and mouse［J］. Hum Mol Genet, 2000, 9(12): 1829-1841.
［15］Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, Furuta H, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus［J］. Nat Genet, 2008, 40(9):1092-1097.
［16］Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, Andersen G, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations［J］. Nat Genet, 2008, 40(9): 1098-1102.
［17］Tan JT, Nurbaya S, Gardner D, Ye S, Tai ES, Ng DP.Genetic variation in KCNQ1 associates with fasting glucose and beta-cell function: a study of 3,734 subjects comprising three ethnicities living in Singapore［J］. Diabetes, 2009, 58(6): 1445-1449.
［18］Mancini-DiNardo D, Steele SJ, Ingram RS, Tilghman SM. A differentially methylated region within the gene Kcnq1 functions as an imprinted promoter and silencer［J］. Hum Mol Genet, 2003, 12(3): 283-294.
